Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases

Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to a targeted complementary molecule. As potential recognition elements with promising diagnostic and therapeutic applications, aptamers, such as monoclonal antibodies, could provide many treatment and diagnostic options for blood diseases. Aptamers present several superior features over antibodies, including a simple in vitro selection and production, ease of modification and conjugation, high stability, and low immunogenicity. Emerging as promising alternatives to antibodies, aptamers could overcome the present limitations of monoclonal antibody therapy to provide novel diagnostic, therapeutic, and preventive treatments for blood diseases. Researchers in several biomedical areas, such as biomarker detection, diagnosis, imaging, and targeted therapy, have widely investigated aptamers, and several aptamers have been developed over the past two decades. One of these is the pegaptanib sodium injection, an aptamer-based therapeutic that functions as an anti-angiogenic medicine, and it is the first aptamer approved by the U.S. Food and Drug Administration (FDA) for therapeutic use. Several other aptamers are now in clinical trials. In this review, we highlight the current state of aptamers in the clinical trial program and introduce some promising aptamers currently in pre-clinical development for blood diseases.     

Direct observation of morphological differences as a function of reaction temperature in model systems for polyurethane foams

A series of polyurea urethanes was isothermally synthesized from toluene diisocyanate (TDI), water, and trifunctional poly(propylene oxide) in the temperature range of 50–150°C. Morphologies of the samples vary significantly as a function of reaction temperature. In this system, phase separation competes with polymerization and crosslinking. Both transmission electron microscopy and atomic force microscopy have shown a network type of structure for the 50°C samples, while the 150°C samples appear to be homogeneous. Infrared analysis shows that samples prepared at 150°C possess a morphology that is less strongly hydrogen bonded and has a broader distribution of hydrogen-bonded states compared to those prepared at lower temperatures. From this combination of techniques, it can be inferred that phase separation occurs faster than crosslinking at low temperatures; consequently, a phase-separated morphology forms. In contrast, crosslinking occurs faster than phase separation at higher reaction temperatures. © 1998 John Wiley & Sons, Inc. J Polym Sci B: Polym Phys 36: 3065–3077, 1998     

The Metabolostasis Network and the Cellular Depository of Aggregation-Prone Metabolites

The vital role of metabolites across all branches of life and their involvement in various disorders have been investigated for decades. Many metabolites are poorly soluble in water or in physiological buffers and tend to form supramolecular aggregates. On the other hand, in the cell, they should be preserved in a pool and be readily available for the execution of biochemical functions. We thus propose that a quality-control network, termed “metabolostasis”, has evolved to regulate the storage and retrieval of aggregation-prone metabolites. Such a system should control metabolite concentration, subcellular localization, supramolecular arrangement, and interaction in dynamic environments, thus enabling normal cellular physiology, healthy development, and preventing disease onset. The paradigm-shifting concept of metabolostasis calls for a reevaluation of the traditional view of metabolite storage and dynamics in physiology and pathology and proposes unprecedented directions for therapeutic targets under conditions where metabolostasis is imbalanced.     

Polymeric conjugates of drugs and antibodies for site-specific drug delivery

The synthesis of targetable conjugates of doxorubicin bound to N-(2-hydroxypropyl)methacrylamide copolymers was investigated. Anti-CD3 antibody against TCR/CD3 complex was used to target the conjugates to T-cells. The effect of structure of the oligopeptide spacer between the drug and polymer as well as of the polymer modification with the antibody on the rate of drug release from the polymeric carrier system incubated in vitro with cathepsin B or with a mixture of intracellular enzymes (tritosomes) is discussed. The results of in vitro drug-release experiments are correlated with the evaluation of T-cell cytotoxicity of targeted and nontargeted polymer-bound doxorubicin conjugates measured in vitro as the inhibition of Con-A stimulated growth of human peripheral blood lymphocytes (³H-thymidine incorporation method).     

ChemInform Abstract: Coordination of Cu+ and Cu2+ Ions in ZSM‐5 in the Vicinity of Two Framework Al Atoms.

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.     

The distributions of enhancement factors in close‐packed and nonclose‐packed surface‐enhanced Raman substrates

A method employing photochemical hole burning, previously developed to measure the distribution of Raman enhancement factors on a nanostructured substrate for surface‐enhanced Raman scattering, is used to compare the enhancement distributions of benzenethiol adsorbed on substrates optimized for 532 nm laser excitation consisting of close‐packed (CP) or nonclose‐packed (NCP) nanospheres. The ensemble‐averaged Raman enhancement factor was 2.8 times smaller for the NCP substrate. The measured distributions revealed additional information. For instance, 92% of the molecules on the CP substrate and 93.6% of the molecules on the NCP substrate had Raman enhancements below average. The minimum enhancements on both substrates were ~10⁴, but on the NCP substrate the maximum enhancement was 1.2 × 10⁸, whereas on the CP substrate the maximum was 2 × 10¹⁰. The Ag‐coated nanospheres form hemisphere‐on‐cylinder mushroom‐like structures on both lattices, but on the NCP lattice, one third of the molecules are on the flat regions between the mushrooms. The flats on the NCP lattice have enhancements of ~10⁴, showing they are part of a resonant plasmonic structure. The highest NCP enhancements of ~10⁸ are tentatively associated with regions at the bases of the mushrooms, whereas the highest CP enhancements of 2 × 10¹⁰ are tentatively associated with gaps between nanospheres where 0.0025% of the molecules reside. Copyright © 2011 John Wiley & Sons, Ltd.